356 related articles for article (PubMed ID: 23181780)
1. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation.
Galindo GR; Garrett-Walker JJ; Hazelton P; Lane T; Steward WT; Morin SF; Arnold EA
Implement Sci; 2012 Nov; 7():116. PubMed ID: 23181780
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of PrEP among MSM and transgender communities-Qualitative findings from two metropolitan cities in India.
Ramanaik S; Sinha AP; Mukherjee A; Pujar A; Subramanyam K; Gopalan A; Washington R
PLoS One; 2023; 18(2):e0281984. PubMed ID: 36812258
[TBL] [Abstract][Full Text] [Related]
3. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
Sevelius JM; Keatley J; Calma N; Arnold E
Glob Public Health; 2016; 11(7-8):1060-75. PubMed ID: 26963756
[TBL] [Abstract][Full Text] [Related]
4. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
[TBL] [Abstract][Full Text] [Related]
5. Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil.
Hoagland B; De Boni RB; Moreira RI; Madruga JV; Kallas EG; Goulart SP; Cerqueira N; Torres TS; Luz PM; Fernandes NM; Liu AY; Grinsztejn B; Veloso VG;
AIDS Behav; 2017 May; 21(5):1278-1287. PubMed ID: 27531461
[TBL] [Abstract][Full Text] [Related]
6. Strategies to Close the PrEP Uptake Gap Among Transgender People and Men Who Have Sex with Men in Tshwane, South Africa: Perspectives from the Community.
Perez-Urbano I; Dilraj A; Pitsi A; Hlongwane N; Abdelatif N; Dietrich J; Ahmed K
AIDS Behav; 2024 Jun; 28(6):1999-2014. PubMed ID: 38427124
[TBL] [Abstract][Full Text] [Related]
7. Pre-exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population.
Uthappa CK; Allam RR; Pant R; Pal S; Dinaker M; Oruganti G; Yeldandi VV
HIV Med; 2018 Apr; 19(4):243-251. PubMed ID: 29178158
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in Northern Thailand.
Yang D; Chariyalertsak C; Wongthanee A; Kawichai S; Yotruean K; Saokhieo P; Guadamuz T; Suwanvanichkij V; Beyrer C; Chariyalertsak S
PLoS One; 2013; 8(10):e76650. PubMed ID: 24116132
[TBL] [Abstract][Full Text] [Related]
9. Who Will Use Pre-Exposure Prophylaxis (PrEP) and Why?: Understanding PrEP Awareness and Acceptability amongst Men Who Have Sex with Men in the UK--A Mixed Methods Study.
Frankis J; Young I; Flowers P; McDaid L
PLoS One; 2016; 11(4):e0151385. PubMed ID: 27093430
[TBL] [Abstract][Full Text] [Related]
10. Attitudes, Beliefs, and Barriers to PrEP Among Trans Men.
Rowniak S; Ong-Flaherty C; Selix N; Kowell N
AIDS Educ Prev; 2017 Aug; 29(4):302-314. PubMed ID: 28825860
[TBL] [Abstract][Full Text] [Related]
11. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.
Golub SA; Gamarel KE; Rendina HJ; Surace A; Lelutiu-Weinberger CL
AIDS Patient Care STDS; 2013 Apr; 27(4):248-54. PubMed ID: 23565928
[TBL] [Abstract][Full Text] [Related]
12. Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies.
Wilson EC; Turner CM; Arayasirikul S; Lightfoot M; Scheer S; Raymond HF; Liu A
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25539. PubMed ID: 32602642
[TBL] [Abstract][Full Text] [Related]
13. Knowledge and Acceptability of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Ghana.
Ogunbajo A; Leblanc NM; Kushwaha S; Boakye F; Hanson S; Smith MDR; Nelson LE
AIDS Care; 2020 Mar; 32(3):330-336. PubMed ID: 31597455
[TBL] [Abstract][Full Text] [Related]
14. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
[TBL] [Abstract][Full Text] [Related]
15. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
[TBL] [Abstract][Full Text] [Related]
16. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
Klein A; Golub SA
AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
[TBL] [Abstract][Full Text] [Related]
17. Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075.
Sandfort TGM; Kreniske P; Mbeda C; Reynolds D; Tshabalala G; Madiwati B; Ogendo A; Dominquez K; Panchia R; Gondwe D; Hamilton EL; Guo X; Cummings V
AIDS Behav; 2024 Jul; 28(7):2361-2377. PubMed ID: 38761334
[TBL] [Abstract][Full Text] [Related]
18. A Promising PrEP Navigation Intervention for Transgender Women and Men Who Have Sex with Men Experiencing Multiple Syndemic Health Disparities.
Reback CJ; Clark KA; Rünger D; Fehrenbacher AE
J Community Health; 2019 Dec; 44(6):1193-1203. PubMed ID: 31317438
[TBL] [Abstract][Full Text] [Related]
19. "I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya.
Kimani M; van der Elst EM; Chirro O; Wahome E; Ibrahim F; Mukuria N; de Wit TFR; Graham SM; Operario D; Sanders EJ
PLoS One; 2021; 16(1):e0244226. PubMed ID: 33465090
[TBL] [Abstract][Full Text] [Related]
20. Facilitators and Barriers to Participation in PrEP HIV Prevention Trials Involving Transgender Male and Female Adolescents and Emerging Adults.
Fisher CB; Fried AL; Desmond M; Macapagal K; Mustanski B
AIDS Educ Prev; 2017 Jun; 29(3):205-217. PubMed ID: 28650227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
